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Abstract
Background: The early recognition of meningococcal disease in children is vital. During the prodrome however,
meningococcal infection presents similarly to many self-limiting viral infections. This mandates a cautious approach
with many children receiving unnecessary broad-spectrum parenteral antibiotics. Advances in nucleic acid
amplification techniques mean that it is now possible to test for Neisseria meningitidis DNA using Loop-mediated-
isothermal AMPlification (LAMP). This technique is quicker than traditional PCR techniques and can be performed
using simple equipment.
Methods: Prior to performing this systematic review, a protocol was developed adhering to PRISMA P standards
and underwent full external peer review. This systematic review was registered with PROSPERO (CRD42017078026).
The index test assessed was LAMP for Neisseria meningitidis and the reference standard was culture or qPCR of a
sterile site detecting Neisseria meningitidis.
Results: We identified 95 records in total: 94 records from the electronic databases and 1 additional study from the
grey literature. After removal of duplicates, 36 studies were screened, and 31 studies excluded based on the title/
abstract. Five full text studies underwent full text review and three studies, including 2243 tests on 1989 patients
aged between 7 days and 18 years were included in the final systematic review. In all studies the LAMP assay and
qPCR primers were directed against the ctrA region of the Neisseria meningitidis bacteria. The diagnostic accuracy of
LAMP testing for invasive meningococcal disease was reported as high (sensitivity 0.84–1.0 and specificity 0.94–1.0)
in all studies irrespective of the sample tested (CSF, Blood, Swab).
Conclusions: We included three studies with 2243 tests on 1989 patients using CSF, blood samples or naso/
oropharyngeal swabs. The studies were all of a high quality and deemed at low risk of bias. Results show that
LAMP testing on blood and CSF was highly accurate when compared to qPCR/culture.
LAMP testing for Neisseria meningitidis is fast and highly accurate and therefore has the potential to be used to
rapidly rule in/out meningococcal disease in children. Given the life-threatening nature of meningococcal infection
further research is required to demonstrate the safety and efficacy of using LAMP testing for Neisseria meningitidis
as a rule in/out test.
Trial registration: This systematic review was registered prospectively with PROSPERO on the 29/11/2017
(CRD42017078026).
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Background
Despite successful vaccination programmes meningococ-
cal disease (MD) remains a leading infectious cause of
septicaemia and death in children worldwide [1–5]. The
early diagnosis of MD significantly improves outcomes
with reduced morbidity and mortality. The challenge is
however, that during the prodrome invasive MD is indistin-
guishable from many self-limiting viral infections [4–6]. This
mandates a cautious approach to the management of these
children with many receiving parenteral antibiotics pending
culture results [7]. Despite this approach children are still
being diagnosed late due to the difficulties in identifying
children who have MD as opposed to a simple viral illness
[4, 7], while many more are being treated “just in case”.
Currently there is no biomarker, or combination of
biomarkers, with sufficient diagnostic accuracy to be
used as rule in/ rule out tests for invasive MD in chil-
dren [8–13]. Attention has therefore moved towards fas-
ter and easier molecular testing to allow for earlier
diagnosis. This has several potential benefits (i) rapid
diagnosis of invasive MD at presentation could help to
tailor initial treatment (ii) rapid exclusion of invasive
MD could shorten the course of parental antibiotics, fa-
cilitate earlier discharge or appropriately direct the clini-
cian’s attention towards other infectious diseases.
Rapid molecular testing exists in the form of Loop-
mediated-isothermal AMPlification (LAMP) for Neis-
seria meningitidis [14–16]. The LAMP is a form of nu-
cleic acid amplification that utilises specific looped
primers and strand displacing DNA polymerase. LAMP
has several advantages over traditional PCR techniques
including (i) quicker testing, typically performed in
under an hour (ii) it requires simpler equipment (iii)
compared to PCR, LAMP is highly tolerant of biological
fluids facilitating direct testing of clinical material [15–20].
It may therefore be possible to move molecular testing
from centralised laboratories to clinical areas thereby sig-
nificantly reducing time to diagnosis.
A systematic review is required to inform on the diag-
nostic accuracy of meningococcal LAMP in the paediat-
ric population. Data from this systematic review will be
useful in the development of clinical practice guidelines
and for policy makers.
The aim of this systematic review was to determine
the diagnostic accuracy of meningococcal LAMP in pre-
dicting and diagnosing invasive MD - defined as the
identification of Neisseria meningitidis from a sterile site,
blood or Cerebrospinal Fluid (CSF), using either
Real-time PCR (e.g.TaqMan® PCR) or bacterial culture.
In children less than 18 years of age.
Methods
Prior to conducting this systematic review a protocol was
produced in adherence to the standards of the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) and registered prospectively on the 29/11/2017
with the International Prospective Register of Systematic Re-
views (PROSPERO) - registration number CRD42017078026
[21, 22]. The protocol has undergone external peer review
and was published in 2018 [23]. We used the Cochrane rec-
ommendations for reporting systematic reviews and
meta-analysis of diagnostic accuracy studies [24].
Eligibility criteria
We included all prospective, retrospective and rando-
mised controlled trials that assessed the performance of
LAMP in children (< 18 years of age) with potential inva-
sive meningococcal disease. For the purpose of this re-
view the index test was defined as LAMP testing for
Neisseria meningitidis. Index testing could have been
performed using blood, cerebrospinal fluid and naso/oro-
pharyngeal swabs. Commercial and laboratory developed
tests were eligible. The reference standard was identifica-
tion of Neisseria meningitidis from a sterile site (blood or
CSF) using either bacterial culture or real-time PCR.
Why include naso/oropharyngeal swabs?
Naso/oropharyngeal swabs are minimally invasive and
easy to collect in young children when compared with
blood and CSF samples. Given that Neisseria meningiti-
dis typically invades through the naso/oral mucosa it
may be possible to tests naso/oropharyngeal swabs to
predict those children with early invasive meningococcal
infection [25]. The potential disadvantage of this ap-
proach however, is that detection of harmless carriage
may reduce the specificity of this approach. Carriage
rates of capsular strains of Neisseria meningitidis are
however, typically low in early childhood increasing to a
peak in adolescence [26, 27]. It may therefore be possible
to use naso/oropharyngeal swab testing as an early and
reliable predictor of disease in young children [26].
Information sources and search strategies
An electronic search strategy was developed in collabor-
ation with the Queen’s University Belfast Medical Librar-
ian (RF). We searched MEDLINE, Embase, Web of
Science, Scopus and the Cochrane Library inclusive of
Cochrane Controlled Trials Register from inception to
10th May 2018. We did not apply language restrictions.
The Medline search strategy is attached as a Add-
itional file 1. In addition, we contacted the manufac-
turers of commercially available meningococcal LAMP
tests and searched conference abstracts.
Study selection and data extraction
Two reviewers (TW, MDS) independently screened all ab-
stracts and titles against inclusion criteria and assessed full
text publications for eligibility. The same two reviewers
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independently judged study quality using the Quality As-
sessment of Diagnostic Accuracy Studies (QUADAS-2)
tool [28]. Disagreements were resolved by consensus or
arbitration by a third party (DF).
Using a pre-piloted data extraction tool (see Add-
itional file 2), two reviewers (TW, MDS) independently
extracted the following information:
 Study characteristics: author, year of publication, country,
design, sample size, clinical setting, number studied,
number of drop-outs with reason, and funding source.
 Population characteristics: inclusion/exclusion
criteria; patient demographics
 LAMP Testing: timing of sampling; method of
sampling (e.g naso/oropharyngeal swab, blood, CSF)
 Gold standard: Real-time PCR (e.g.TaqMan® PCR)
or sterile site bacterial culture (i.e blood/CSF)
 Outcomes: True positives, false positives, true
negatives, and false negatives were extracted to
construct a diagnostic contingency (2-by-2) table.
Data analysis
Statistical analysis and data synthesis were performed by
TW and LAMP test result data were compared to the
reference test. The true positive, true negative, false posi-
tive and false negative rate were recorded and used to
create a 2 × 2 tables. From these tables inferred statistics
were calculated including sensitivity and specificity with
95% confidence intervals. Meta-analysis to provide
pooled sensitivity and specificity data were not per-
formed due to the small number of studies available. All
analysis was performed using Review Manager (RevMan)
Version 5.3. Copenhagen: The Nordic Cochrane Centre,
The Cochrane Collaboration, 2014.
Results
Study inclusion
We identified 95 records in total: 94 records from the
electronic databases and 1 additional study from the grey
literature. After removal of duplicates, 36 studies were
screened, and 31 studies excluded based on the title/ab-
stract. All of the 31 studies screened and excluded were
not relevant to the systematic review. Five full text studies
underwent full text review, and three studies were in-
cluded in the final systematic review (see Fig. 1). The two
studies excluded both used “spiked specimens” as opposed
to true clinical specimens [19, 29]. Spiked specimens in-
volve the adding of Neisseria meningitidis DNA to human
specimens as opposed to detecting wild type Neisseria
meningitidis in disease.
Study characteristics and risk of bias
Three studies including 2243 tests on 1989 patients aged
between 7 days and 18 years were included [14–16]. All
three studies were cohort studies, two were conducted
in the United Kingdom and one in Vietnam, China and
Korea [14–16]. In all studies the LAMP assay and qPCR
primers were directed against the ctrA region of the
Neisseria meningitidis bacteria. The ctrA gene sequence
is genetically conserved across all pathogenic (capsular)
strains of the Neisseria meningitidis bacteria. Study char-
acteristics are outlined in Table 1. In total there were
1595 tests using CSF samples, 345 using blood samples
and 396 using naso/oropharyngeal swabs.
The study by McKenna et al. was performed in the UK
in both adults and children with a total 267 patients re-
cruited. The age range was 7 days to 57 years and the
median age was 1 year (16). Of the 267 patients 256 were
children under 18 years of age. We contacted the corre-
sponding author and obtained the dataset pertaining
only to those participants under 18 years of age. These
data included 256 separate patients with 203 individual
blood samples (either serum or EDTA), 21 patients with
CSF samples and 155 patients with naso/oropharyngeal
swabs including “respiratory swabs”. The study by
Bourke et al. included 148 patients aged 17 days to 12
years of age and was performed in the UK. Of the 148
patients 141 had naso/oropharyngeal swab results and
144 had blood results. There was also an analysis of 8
CSF samples of which 7 had both LAMP and qPCR re-
sults (15). The study by Lee et al. included 1574 patients
under 5 years of age with suspected meningitis recruited
from across Vietnam, China and Korea. All children
underwent both LAMP and qPCR on CSF samples.
The methodological quality of the studies was judged
as at low risk of bias (Fig. 2). In all instances the refer-
ence test was performed blinded to the result of the test
being evaluated.
Diagnostic accuracy
The diagnostic accuracy of LAMP testing for invasive
meningococcal disease was reported as high (sensitivity
0.84–1.0 and specificity 0.94–1.0) in all studies irrespect-
ive of the sample tested (CSF, Blood, Swab) (See Fig. 3).
LAMP (blood)
Two of the studies (Bourke et al. and McKenna et al),
with 345 patients combined, provided diagnostic accur-
acy on LAMP testing for Neisseria meningitidis on blood
specimens (either EDTA or Serum) [15, 16]. The sensi-
tivity was reported as high in both the Bourke et al.
study 0.85(95%CI 0.65 to 0.96) and the McKenna et al.
study1.00(95%CI 0.81 to 1.00). The specificity of LAMP
testing for Neisseria meningitidis on blood was also re-
ported as high in both the Bourke et al. study
1.00(95%CI 0.97 to 1.00) and the McKenna et al. study
0.99(95%CI 0.96 to 1.00) [15, 16]. The number of studies
was too small to perform a meta-analysis and report a
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pooled sensitivity or specificity of blood LAMP testing
for Neisseria meningitidis. These data are summarised in
Fig. 3.
Lamp (CSF)
All three studies including 1602 patients provided diag-
nostic accuracy data on LAMP testing for Neisseria
meningitidis on CSF specimens [14–16]. Of these 1574
came from a single study by Lee et al. [14]. The sensitiv-
ity and specificity was reported as high in the largest co-
hort reported by Lee et al. 1.00(95%CI 0.86 to 1.00) and
1.00(95%CI 0.99 to 1.00) respectively [14]. LAMP testing
of CSF was also found to be highly sensitive in the other
two smaller studies with Bourke et al. reporting the sen-
sitivity as 1.00(0.59 to 1.00) and McKenna et al. report-
ing the sensitivity as 1.00(0.29 to 1.00) [15, 16]. The
specificity of LAMP testing for Neisseria meningitidis on
CSF specimens was reported as high in the study by Mc-
Kenna et al. 0.94(95%CI 0.73 to 1.00). The number of
studies was too small to perform a meta-analysis and
report a pooled sensitivity or specificity of CSF LAMP
testing for Neisseria meningitidis. These data are sum-
marised in Fig. 3.
LAMP (naso/oropharyngeal swabs)
Two of the studies (Bourke et al. and McKenna et al),
with 296 patients combined, provided diagnostic accur-
acy on LAMP testing for Neisseria meningitidis on naso/
oropharyngeal swab specimens [15, 16]. The sensitivity
was reported as high in both the Bourke et al. study
0.84(95% 0.64 to 0.95) and the McKenna et al. study
1.00(95%CI 0.77 to 1.00). The specificity of LAMP test-
ing for Neisseria meningitidis on naso/oropharyngeal
swab specimens was also reported as high in both the
Bourke et al. study 1.00(95%CI 0.97 to 1.00)and the Mc-
Kenna et al. study 0.99(95%CI 0.96 to 1.00) [15, 16]. The
number of studies was too small to perform a
meta-analysis and report a pooled sensitivity or specifi-
city of blood LAMP testing for Neisseria meningitidis.
These data are summarised in Fig. 3.
Fig. 1 PRISMA Flow Diagram
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Discussion
This review was designed to determine the accuracy of
LAMP testing for Neisseria meningitidis when compared
to the existing reference standard of either Real-time
PCR (e.g.TaqMan® PCR) or bacterial culture in children
less than 18 years of age.
We included three studies with 2243 tests on 1989 pa-
tients using CSF, blood samples or naso/oropharyngeal
swabs. The studies were all of a high quality and deemed
at low risk of bias. Results show that LAMP testing on
blood and CSF was highly accurate when compared to
qPCR/culture with a sensitivity ranging from 0.85 to
1.00 and a specificity ranging from 0.94 to 1.00.
Similarly testing of naso/oropharyngeal swabs was
highly accurate for predicting those children with inva-
sive meningococcal disease (Blood/CSF positive qPCR or
bacterial culture) with a sensitivity ranging from 0.84 to
1.00 and a specificity reported at 1.00. This is likely due
to a combination of factors including (i) the LAMP as-
says used were directed against the ctrA region thereby
only detecting pathogenic strains of Neisseria meningiti-
dis that are typically associated with invasive disease and
(ii) low carriage rates of capsular Neisseria meningitidis
in young children. These findings raise the possibility
that in young children that LAMP testing of naso/oro-
pharyngeal swabs for Neisseria meningitidis could be
used as a non-invasive and rapid test to identify those as
risk of invasive meningococcal disease.
Further prospective research is required to determine
where in the diagnostic pathway Neisseria meningitidis
LAMP testing could be used and which specimen type is
ideal. LAMP testing can be performed in under one
hour in most instances suggesting it could be used (i)
prior to initiation of antibiotic therapy or (ii) to tailor
Fig. 2 Risk of bias and applicability concerns summary
Fig. 3 Reported diagnostic accuracy by study and test with forest plots
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antibiotic therapy. The potential benefits of earlier diag-
nosis or exclusion of invasive MD include (i) redirecting
the clinical team to other potential diagnoses (ii) earlier
tailoring or stopping of antibiotic therapy (iii) potential
shorter periods of hospital admission (iv) improved
anti-microbial stewardship.
If LAMP testing for Neisseria meningitidis is to be
used as a rapid rule out test as suggested above, then
further studies are required to demonstrate the safety of
this approach. The overall sensitivity of LAMP testing is
high 0.85 to 1.00 but the existing studies using blood
and naso-oropharyngeal swab testing are small with
wide confidence intervals. Given the life-threatening na-
ture of meningococcal infection it is important that any
use of LAMP as a rule out test has excellent sensitivity
and can be shown to be safe in clinical practice.
Limitations
This systematic review has a number of limitations. The
number of diagnostic accuracy studies reporting on
LAMP for Neisseria meningitidis remains small. With
the majority of data available from a single study (14).
This systematic review may also overestimate the diag-
nostic accuracy of LAMP testing on naso/oropharyngeal
swabs to predict invasive meningococcal disease. The ma-
jority of the children in the reviewed studies were under 5
years of age and as such the carriage rates of capsular
Neisseria meningitidis will have been low. Further research
is required to determine the diagnostic test accuracy of
LAMP testing for Neisseria meningitidis on naso/oropha-
ryngeal swabs from older children and adolescents where
carriage rates of capsular Neisseria meningitidis are higher.
Finally, it is entirely possible that LAMP techniques are
more sensitive than the existing reference standard of
qPCR and/or bacterial culture techniques. With LAMP
testing it is possible to detect fewer than 10 copies of bac-
terial DNA. If LAMP testing is more sensitive than the
existing reference standard, then this review would under-
estimate the specificity of LAMP by falsely assuming that
a LAMP positive, but reference standard negative test was
a false positive result.
Additional files
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Additional file 2: LAMP-SR (Data Extraction Tool). (DOCX 58 kb)
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